SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-091926
Filing Date
2024-04-10
Accepted
2024-04-10 16:23:05
Documents
19
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d762054ddef14a.htm   iXBRL DEF 14A 699168
6 GRAPHIC g762054g02g02.jpg GRAPHIC 39722
7 GRAPHIC g762054g03g03.jpg GRAPHIC 19912
8 GRAPHIC g762054g44g44.jpg GRAPHIC 98257
9 GRAPHIC g762054g45g01.jpg GRAPHIC 90915
10 GRAPHIC g762054g45g02.jpg GRAPHIC 96675
  Complete submission text file 0001193125-24-091926.txt   2168832

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cprx-20231231.xsd EX-101.SCH 4039
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20231231_def.xml EX-101.DEF 3302
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20231231_lab.xml EX-101.LAB 4178
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20231231_pre.xml EX-101.PRE 2504
22 EXTRACTED XBRL INSTANCE DOCUMENT d762054ddef14a_htm.xml XML 150671
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 24836072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)